Ticker > Company >

Entero Healthcare share price

Entero Healthcare Solutions Ltd.

NSE: ENTERO BSE: 544122 SECTOR: Trading  8637   4   1

1308.30
+5.70 (0.44%)
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 1316.2

Today's Low

₹ 1270.35

52 Week High

₹ 1583

52 Week Low

₹ 974.45

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

5690.29 Cr.

Enterprise Value

4897.94 Cr.

No. of Shares

4.35 Cr.

P/E

76.45

P/B

3.42

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  382.52

CASH

792.35 Cr.

DEBT

0 Cr.

Promoter Holding

52.44 %

EPS (TTM)

₹  17.11

Sales Growth

79.05%

ROE

4.98 %

ROCE

4.06%

Profit Growth

408.63 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year79.05%
3 Year44.77%
5 YearNA

Profit Growth

1 Year408.63%
3 Year60.28%
5 YearNA

ROE%

1 Year4.98%
3 Year1.66%

ROCE %

1 Year4.06%
3 Year-0.93%

Debt/Equity

0

Price to Cash Flow

-75.22

Interest Cover Ratio

2.0917

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 52.44 0.00
Jun 2024 52.44 0.00
Mar 2024 52.44 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 60.2817040351508% for the Past 3 years.
  • The company has shown a good revenue growth of 44.7659348406252% for the Past 3 years.
  • The company has significantly decreased its debt by 91.5 Cr.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.591828710213445.
  • The company has an efficient Cash Conversion Cycle of 69.9248 days.
  • Company has a healthy liquidity position with current ratio of 12.9943.
  • The company has a high promoter holding of 52.44%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 17.2852748749158.

 Limitations

  • Company has a poor ROE of 1.65893333333333% over the past 3 years.
  • Company has a poor ROCE of -0.929182329345107% over the past 3 years
  • Company has contingent liabilities of 477.7 Cr.
  • Company has negative cash flow from operations of -75.65.
  • Tax rate is low at -57.7673.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 76.45.
  • The company is trading at a high EV/EBITDA of 56.2799.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 76.59 106.56 122.38 112.83
Total Expenditure 85.08 115.75 124.23 118.91
Operating Profit -8.5 -9.19 -1.85 -6.08
Other Income 16.25 42.4 32.17 28.81
Interest 4.73 5.61 0.41 0.39
Depreciation 2.32 1.73 2.17 2.13
Exceptional Items 0 0 0 0
Profit Before Tax 0.7 25.87 27.74 20.22
Tax -0.25 -11.41 6.87 4.89
Profit After Tax 0.95 37.28 20.88 15.33
Adjusted EPS (Rs) 0.59 8.57 4.8 3.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 104.87 137.29 177.69 318.16
Total Expenditure 136.84 191 221.61 352.66
Operating Profit -31.98 -53.72 -43.92 -34.49
Other Income 23.43 26.87 52.57 89.93
Interest 2.26 5.29 11.3 22.32
Depreciation 7.35 8.71 9.8 8.75
Exceptional Items 0 0 0 0
Profit Before Tax -18.15 -40.85 -12.46 24.37
Tax 0 0 0 -14.08
Net Profit -18.15 -40.85 -12.46 38.44
Adjusted EPS (Rs.) -1815.2 -106.1 -30.29 8.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 517.21 622.84 667.73 43.49
Total Reserves -30.78 -71.63 -83.99 1582.92
Borrowings 0 0 28 0
Other N/C liabilities 21.46 22.92 17.23 0.31
Current liabilities 24.81 79.96 134.61 127.82
Total Liabilities 532.71 654.08 763.57 1754.54
Assets
Net Block 50.19 51.42 40.65 34.44
Capital WIP 0 0 0 0
Intangible WIP 2.24 0.05 0 0
Investments 38.71 39.43 40.64 40.54
Loans & Advances 5.14 5.91 7.87 13.51
Other N/C Assets 0 0 1.4 5.06
Current Assets 436.43 557.27 673 1660.99
Total Assets 532.71 654.08 763.57 1754.54
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -18.15 -40.85 -12.46 24.37
Adjustment -13.21 -9.38 -29.51 -38.43
Changes in Assets & Liabilities -37.28 6.49 -12.41 -59.79
Tax Paid 0.45 -0.96 -2.53 -1.79
Operating Cash Flow -68.2 -44.7 -56.91 -75.65
Investing Cash Flow -7.21 -68.8 -58.29 -762.69
Financing Cash Flow 75.5 127.48 91.11 925.56
Net Cash Flow 0.09 13.98 -24.09 87.22

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024%
promoters 52.44 52.44 52.44
orbimed asia iii mauritiu... 38.03 38.03 38.03
prabhat agrawal 9.26 9.26 9.26
prem sethi 5.15 5.15 5.15
PARTICULARS Mar 2024% Jun 2024% Sep 2024%
investors 47.56 47.56 47.56
clsa global markets pte. ... 5.45 4.76 2.51
government of singapore 5.03 5.93 6.22
invesco india aggressive ... - - 4.74
llp - 0.02 0.08
smallcap world fund, inc 4.04 4.60 4.60
stichting depositary apg ... - - 2.13
surbhi singh - prasid uno... - - 10.46
surbhi singh - prasid uno... - 15.98 -
prasid uno family trust (... 15.98 - -

Annual Reports

Ratings & Research Reports

Company Presentations

Entero Healthcare Stock Price Analysis and Quick Research Report. Is Entero Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Entero Healthcare stock price today is Rs 1302.85. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Entero Healthcare . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Entero Healthcare has a PE ratio of 76.133069982703 which is high and comparatively overvalued .

  • Share Price: - The current share price of Entero Healthcare is Rs 1302.85. One can use valuation calculators of ticker to know if Entero Healthcare share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Entero Healthcare has ROA of 3.0531 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Entero Healthcare has a Current ratio of 12.9943 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Entero Healthcare has a ROE of 4.9768 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Entero Healthcare has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Entero Healthcare has reported revenue growth of 79.054 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Entero Healthcare for the current financial year is -10.841680784257 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Entero Healthcare is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Entero Healthcare is Rs 17.1128 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Entero Healthcare in Ticker for free. Also, one can get the intrinsic value of Entero Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Entero Healthcare
X